Skip to main content

Table 4 Unit costs

From: Cost-effectiveness analysis of pembrolizumab compared to standard of care as first line treatment for patients with advanced melanoma in Hong Kong

Type of health care resourceUnit cost (USD)Resource utilizationTotal cost (unit cost × resource utilization)
Progression free state management cost
 Inpatient admissions
  Time in hospital (days)$600.000.93$55.80
  Time in ICU (days)$29490.003$8.85
 Outpatient admissions
  Hospital visits$142.310.014$1.99
  Office-based visits$49.360.011$0.54
 Radiation
  Radiotherapy sessions$496.150.017$8.43
 Labs
  Hematology$49.360.092$4.54
  Chemistry—n (%)$116.030.094$10.91
  Thyroid function—n (%)$79.490.037$2.94
  ACTH simulation test—n (%)$311.340.008$2.49
 Imaging
  X-ray$24.360.003$0.07
  PET/CT scan$1339.740.025$33.49
  MRI$1000.000.013$13.00
  Ultrasonography$256.410.004$1.03
Total cost$144.09
Progressive disease state management cost
 Inpatient admissions
  Time in hospital (days)$600.000.078$46.80
 Outpatient admissions
  Hospital visits$142.310.002$0.28
  Office-based visits$49.360.005$0.25
  Emergency care visits$126.920.001$0.13
 Radiation
  Radiotherapy sessions$496.150.019$9.43
 Labs
  Hematology$49.360.038$1.88
  Chemistry—n (%)$116.030.033$3.83
  Thyroid function—n (%)$79.490.021$1.67
  ACTH simulation test—n (%)$311.340.001$0.31
 Imaging
  X-ray$24.360.001$0.02
  PET/CT scan$1339.740.023$30.81
  MRI$1000.000.012$12.00
  Ultrasonography$256.410.007$1.79
Total cost$109.20